Full Issue PDF.
- Published in:
- Advances in Pulmonary Hypertension, 2025, v. 23, n. 2, p. 1, doi. 10.21693/1933-0898-23.2.i
- Publication type:
- Article
Works matching IS 1933088X AND DT 2025 AND VI 23 AND IP 2
Results: 9
1
2
Pulmonary Artery Intimal Sarcoma and the Role for Vasodilator Therapy—A Case Report and Scoping Review.
- Published in:
- Advances in Pulmonary Hypertension, 2025, v. 23, n. 2, p. 64, doi. 10.21693/1933-088X-23.2.64
- By:
- Publication type:
- Article
3
Racial and Ethnic Equity in Pulmonary Arterial Hypertension Clinical Trials.
- Published in:
- Advances in Pulmonary Hypertension, 2025, v. 23, n. 2, p. 59, doi. 10.21693/1933-088X-23.2.59
- By:
- Publication type:
- Article
4
Tyrosine Kinase Inhibitors for Treatment of Pulmonary Arterial Hypertension.
- Published in:
- Advances in Pulmonary Hypertension, 2025, v. 23, n. 2, p. 56, doi. 10.21693/1933-088X-23.2.56
- By:
- Publication type:
- Article
5
CardioMEMS<sup>®</sup> and Remote Hemodynamic Monitoring in Pulmonary Hypertension.
- Published in:
- Advances in Pulmonary Hypertension, 2025, v. 23, n. 2, p. 48, doi. 10.21693/1933-088X-23.2.48
- By:
- Publication type:
- Article
6
New Treatment Pathways, Drug Development and Clinical Trial Designs: Incorporation of Risk Stratification.
- Published in:
- Advances in Pulmonary Hypertension, 2025, v. 23, n. 2, p. 43, doi. 10.21693/1933-088X-23.2.43
- By:
- Publication type:
- Article
7
Multiomics Integration for Identifying Treatment Targets, Drug Development, and Diagnostic Designs in PAH.
- Published in:
- Advances in Pulmonary Hypertension, 2025, v. 23, n. 2, p. 33, doi. 10.21693/1933-088X-23.2.33
- By:
- Publication type:
- Article
8
Guest Editors' Memo.
- Published in:
- 2025
- By:
- Publication type:
- Editorial
9
Editor's Memo.
- Published in:
- 2025
- By:
- Publication type:
- Editorial